Lungs respond to hospital ventilator as if it were an infection
When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immune response that can lead to excessive inflammation, new research suggests.
While learning that lungs perceive the ventilation as an infection, researchers also discovered potential drug targets that might reduce the resulting inflammation - a tiny piece of RNA and two proteins that have roles in the immune response.
Using human cell cultures, Ohio State University researchers determined that mechanical pressures trigger an innate immune response - the same immune response that the body launches to begin its fight against any kind of infection.
The rhythmic pressure of ventilation stimulated the production of pro-inflammatory chemicals by activating proteins called toll-like receptors (TLRs) in lung cells, the research showed.
"We showed that these cells respond to a mechanical force, pressure, as if it were an inflammatory stimulus. They almost perceive it as a bacterial toxin - and they don't like it," said Samir Ghadiali, associate professor of biomedical engineering at Ohio State and co-lead author of the study. "We didn't know until this study how we could possibly turn off that type of mechanically induced inflammation. Essentially what we found are two things that may help: microRNAs and two TLRs in the innate immunity pathway."
The job of TLRs is to recognize distinctive characteristics of pathogens and send out signals to activate other players in the immune system. This response persists during ventilation even with no pathogen present, and the prolonged inflammation can lead to organ failure. Acute lung injuries requiring mechanical ventilation lead to more deaths annually than do breast cancer and prostate cancer combined.
The study also suggested that at least one tiny piece of RNA - called a microRNA - is influential in this immune response because its behavior regulates the activation of the toll-like receptor proteins. The findings suggest that manipulating levels of either the microRNA or TLRs could be the basis for potential new treatment options for acute lung injury that requires ventilation.
This study appears online and is scheduled for future print publication in the Journal of the Federation of American Societies for Experimental Biology (FASEB Journal).
The study has clinical relevance as well as an influence on the big picture of the field of mechanotransduction - the study of how a mechanical force gets changed into a chemical stimulus inside the body. Mechanics play a role in many disease processes, including hardening of the arteries, other cardiac disorders, kidney problems, emphysema and chronic obstructive pulmonary disease, and cancer.
"This work suggests that there may be a ubiquitous inflammatory mechanism that cells have to respond to anything they perceive as a danger," Ghadiali said. "At least in the lung, we now know the innate immunity pathway plays an important role, and this study showed that a mechanical force gets converted into cytokine production through this well-known pathway."
Ventilators are used on patients in intensive care units who are suffering from a variety of conditions that lead to acute respiratory distress syndrome; these include pneumonia, bacterial or viral infections, trauma and sepsis.
Scientists have known for more than a decade that mechanical ventilation causes inflammation in the lungs that lingers after an acute illness has been cleared, but they have had a hard time figuring out why the lungs respond in this way.
Research attempts to reduce lung damage by altering the force of the ventilation pressure, surface tension or breathing rhythm haven't worked out, said Ghadiali, also an investigator in Ohio State's Davis Heart and Lung Research Institute. So his team, co-led by Patrick Nana-Sinkam, associate professor of internal medicine, sought to determine if there might be another way to regulate lung inflammation in ventilated patients.
The researchers first characterized inflammatory effects of mechanical pressure in experiments using human small airway cells from deep inside the lungs, where ventilation pressure tends to do the most damage.
These tests showed that as little as four hours of exposure to ventilation pressure and breathing rates that mimic the clinical environment raised levels of three proinflammatory cytokines, which are chemical messengers that promote an inflammatory response.
"The cells keep secreting compounds to recruit the immune system to fight an infection, but there is no infection. It's a response we don't want," Ghadiali said.
The scientists then tested these same cells to examine what role microRNAs (miRs) might have in the lung's inflammatory response to ventilation. Using powerful computers to screen the cells for which miRs responded to ventilation pressure and cyclic breathing patterns, they identified a clear target for more study: a microRNA known as miR-146a. This microRNA's activation increased in the cells as experimental levels of cyclic ventilation pressure increased.
MicroRNAs are small pieces of RNA that bind to messenger RNA, which contains the instructions for building proteins in the process of gene expression. When that connection is made, however, the microRNA has an inverse relationship to its target protein, meaning an overexpressed microRNA leads to lower levels of the protein that the microRNA regulates.
"We know that these tiny molecules have the ability to regulate fundamental biological processes in disease. However, their role as mediators of mechanically induced inflammation has yet to be explored," Nana-Sinkam said.
The identification of miR-146a led the researchers to explore the role of two toll-like receptor proteins in the inflammatory response to mechanical ventilation. Because miR-146a has been studied for several years, it is known to target two toll-like receptor proteins that in turn are known to regulate production of the proinflammatory cytokines that the lung cells were found to secrete in response to mechanical pressure.
With this relationship established, the researchers tested the effects of manipulating these various players on the lung cells' inflammatory response. Among their key findings: Dramatically driving up levels of miR-146a in human small airway cells under mechanical ventilation conditions lowered the activity of the two TLRs, which in turn led to very little cytokine secretion - meaning inflammation was held at bay.
"So we have a microRNA that we can overexpress that targets the innate immunity pathway and shuts down mechanically induced inflammation," Ghadiali said.
But the miR is not the only potential target, he noted. Therapies could be designed to target the toll-like receptor proteins themselves, as well, to reduce lung inflammation created by both a disease and the ventilation.
The researchers plan to test the effectiveness of experimental drugs that act on these biological targets in upcoming studies on rodents.
Provided by Ohio State University
- A boost in microRNA may protect against sepsis and other inflammatory diseases May 24, 2012 | not rated yet | 0
- Researchers find potential new way to fight sepsis Jun 10, 2011 | not rated yet | 0
- Study reveals new mechanism that might promote cancer's growth and spread in the body Jul 10, 2012 | not rated yet | 0
- Key to out-of-control immune response in lung injury found Aug 16, 2007 | not rated yet | 0
- Study shows how inflammation can lead to cancer Apr 19, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.
Medical research May 23, 2013 | 5 / 5 (1) | 0 |
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...
Medical research May 23, 2013 | not rated yet | 0
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
Medical research May 23, 2013 | 3 / 5 (1) | 0 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Medical research May 23, 2013 | 5 / 5 (3) | 0 |
Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...
Medical research May 23, 2013 | 5 / 5 (2) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
21 hours ago | 5 / 5 (6) | 5
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
21 hours ago | 5 / 5 (1) | 1
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
13 hours ago | not rated yet | 1
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
May 20, 2013 | 4.8 / 5 (31) | 9 |
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
May 22, 2013 | 4.3 / 5 (6) | 6 |
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
21 hours ago | not rated yet | 0